25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men - PubMed (original) (raw)
Multicenter Study
. 2010 Jan 5;74(1):33-41.
doi: 10.1212/WNL.0b013e3181c7197b. Epub 2009 Nov 25.
M L Paudel, B C Taylor, H A Fink, A Ishani, M T Canales, K Yaffe, E Barrett-Connor, E S Orwoll, J M Shikany, E S Leblanc, J A Cauley, K E Ensrud; Osteoporotic Fractures in Men (MrOS) Study Research Group
Collaborators, Affiliations
- PMID: 19940271
- PMCID: PMC2809025
- DOI: 10.1212/WNL.0b013e3181c7197b
Multicenter Study
25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men
Y Slinin et al. Neurology. 2010.
Abstract
Objective: To test the hypothesis that lower 25-hydroxyvitamin D [25(OH)D] levels are associated with a greater likelihood of cognitive impairment and risk of cognitive decline.
Methods: We measured 25(OH)D and assessed cognitive function using the Modified Mini-Mental State Examination (3MS) and Trail Making Test Part B (Trails B) in a cohort of 1,604 men enrolled in the Osteoporotic Fractures in Men Study and followed them for an average of 4.6 years for changes in cognitive function.
Results: In a model adjusted for age, season, and site, men with lower 25(OH)D levels seemed to have a higher odds of cognitive impairment, but the test for trend did not reach significance (impairment by 3MS: odds ratio [OR] 1.84, 95% confidence interval [CI] 0.81-4.19 for quartile [Q] 1; 1.41, 0.61-3.28 for Q2; and 1.18, 0.50-2.81 for Q3, compared with Q4 [referent group; p trend = 0.12]; and impairment by Trails B: OR 1.66, 95% CI 0.98-2.82 for Q1; 0.96, 0.54-1.69 for Q2; and 1.30, 0.76-2.22 for Q3, compared with Q4 [p trend = 0.12]). Adjustment for age and education further attenuated the relationships. There was a trend for an independent association between lower 25(OH)D levels and odds of cognitive decline by 3MS performance (multivariable OR 1.41, 95% CI 0.89-2.23 for Q1; 1.28, 0.84-1.95 for Q2; and 1.06, 0.70-1.62 for Q3, compared with Q4 [p = 0.10]), but no association with cognitive decline by Trails B.
Conclusion: We found little evidence of independent associations between lower 25-hydroxyvitamin D level and baseline global and executive cognitive function or incident cognitive decline.
Figures
Figure Road map of 1,606 participants with baseline 25(OH)D levels 25(OH)D = 25-hydroxyvitamin D; 3MS = Modified Mini-Mental State Examination; Trails B = Trail Making Test Part B.
Similar articles
- Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women.
Slinin Y, Paudel M, Taylor BC, Ishani A, Rossom R, Yaffe K, Blackwell T, Lui LY, Hochberg M, Ensrud KE; Study of Osteoporotic Fractures Research Group. Slinin Y, et al. J Gerontol A Biol Sci Med Sci. 2012 Oct;67(10):1092-8. doi: 10.1093/gerona/gls075. Epub 2012 Mar 27. J Gerontol A Biol Sci Med Sci. 2012. PMID: 22454371 Free PMC article. - Relationship between 25-hydroxyvitamin D and cognitive function in older adults: the Health, Aging and Body Composition Study.
Wilson VK, Houston DK, Kilpatrick L, Lovato J, Yaffe K, Cauley JA, Harris TB, Simonsick EM, Ayonayon HN, Kritchevsky SB, Sink KM; Health, Aging and Body Composition Study. Wilson VK, et al. J Am Geriatr Soc. 2014 Apr;62(4):636-41. doi: 10.1111/jgs.12765. Epub 2014 Mar 17. J Am Geriatr Soc. 2014. PMID: 24635412 Free PMC article. - Serum phosphate and cognitive function in older men.
Slinin Y, Vo T, Taylor BC, Murray AM, Schousboe J, Langsetmo L, Ensrud K; Osteoporotic Fractures in Men (MrOS) Study Group. Slinin Y, et al. Int J Geriatr Psychiatry. 2018 Jan;33(1):159-166. doi: 10.1002/gps.4699. Epub 2017 Mar 22. Int J Geriatr Psychiatry. 2018. PMID: 28326612 Free PMC article. - Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients.
Liu GL, Pi HC, Hao L, Li DD, Wu YG, Dong J. Liu GL, et al. PLoS One. 2015 Dec 2;10(12):e0143782. doi: 10.1371/journal.pone.0143782. eCollection 2015. PLoS One. 2015. PMID: 26630385 Free PMC article. - 25(OH) vitamin D and functional outcomes in older adults admitted to rehabilitation units: the safari study.
Lelli D, Pérez Bazan LM, Calle Egusquiza A, Onder G, Morandi A, Ortolani E, Mesas Cervilla M, Pedone C, Inzitari M. Lelli D, et al. Osteoporos Int. 2019 Apr;30(4):887-895. doi: 10.1007/s00198-019-04845-7. Epub 2019 Jan 16. Osteoporos Int. 2019. PMID: 30652217
Cited by
- Alzheimer's Disease: A Review of Pathology, Current Treatments, and the Potential Therapeutic Effect of Decreasing Oxidative Stress by Combined Vitamin D and l-Cysteine Supplementation.
Jain SK, Stevens CM, Margret JJ, Levine SN. Jain SK, et al. Antioxid Redox Signal. 2024 Apr;40(10-12):663-678. doi: 10.1089/ars.2023.0245. Epub 2023 Dec 8. Antioxid Redox Signal. 2024. PMID: 37756366 Review. - Is There a Role of Vitamin D in Alzheimer's Disease?
Plantone D, Pardini M, Caneva S, De Stefano N. Plantone D, et al. CNS Neurol Disord Drug Targets. 2024;23(5):545-553. doi: 10.2174/1871527322666230526164421. CNS Neurol Disord Drug Targets. 2024. PMID: 37246320 Review. - Association between vitamin D concentration and delirium in hospitalized patients: A meta-analysis.
Fu N, Miao M, Li N, Zeng S, Zhu R, Zhang J. Fu N, et al. PLoS One. 2023 Feb 8;18(2):e0281313. doi: 10.1371/journal.pone.0281313. eCollection 2023. PLoS One. 2023. PMID: 36753475 Free PMC article. Review. - Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases.
Uthaiah CA, Beeraka NM, Rajalakshmi R, Ramya CM, Madhunapantula SV. Uthaiah CA, et al. Mol Neurobiol. 2022 Jul;59(7):4065-4105. doi: 10.1007/s12035-022-02837-z. Epub 2022 Apr 27. Mol Neurobiol. 2022. PMID: 35476289 Review.
References
- Gloth FM III, Gundberg CM, Hollis BW, Haddad JG Jr, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA 1995;274:1683–1686. - PubMed
- Goldray D, Mizrahi-Sasson E, Merdler C, et al. Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 1989;37:589–592. - PubMed
- Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777–783. - PubMed
- Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005;15:S5–S101. - PubMed
- Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AR45632/AR/NIAMS NIH HHS/United States
- 1 R01 HL070838/HL/NHLBI NIH HHS/United States
- R21 DK070713/DK/NIDDK NIH HHS/United States
- AR 049439/AR/NIAMS NIH HHS/United States
- U01AR045654-10/AR/NIAMS NIH HHS/United States
- R01 AG028050-02/AG/NIA NIH HHS/United States
- R01 AG026720/AG/NIA NIH HHS/United States
- AR052000/AR/NIAMS NIH HHS/United States
- U01 AG030644/AG/NIA NIH HHS/United States
- R01AG027576-24/AG/NIA NIH HHS/United States
- R01 AG021918/AG/NIA NIH HHS/United States
- 1 U01 HL79171/HL/NHLBI NIH HHS/United States
- AR45614/AR/NIAMS NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- N01-WH-7-4318/WH/WHI NIH HHS/United States
- R01 DK063300-01A2/DK/NIDDK NIH HHS/United States
- 2 U01 AR045614-08A1/AR/NIAMS NIH HHS/United States
- U01 AG012546-15/AG/NIA NIH HHS/United States
- U01 AR45647/AR/NIAMS NIH HHS/United States
- AG05394/AG/NIA NIH HHS/United States
- 1R21DK076780/DK/NIDDK NIH HHS/United States
- 1 R01AR051124/AR/NIAMS NIH HHS/United States
- U01 AR45614/AR/NIAMS NIH HHS/United States
- R01 DK069406/DK/NIDDK NIH HHS/United States
- CA37429/CA/NCI NIH HHS/United States
- U01 AR045614/AR/NIAMS NIH HHS/United States
- U01 AR45654/AR/NIAMS NIH HHS/United States
- N01 HC48047/HC/NHLBI NIH HHS/United States
- U01 AR045654/AR/NIAMS NIH HHS/United States
- 5 R01 HL70837/HL/NHLBI NIH HHS/United States
- AG07181/AG/NIA NIH HHS/United States
- N01 CN75022/CN/NCI NIH HHS/United States
- P60 AR054731-02/AR/NIAMS NIH HHS/United States
- 3U54CA118948/CA/NCI NIH HHS/United States
- 5P60MD00502-04/MD/NIMHD NIH HHS/United States
- U01-AG027810/AG/NIA NIH HHS/United States
- U01 AR045583/AR/NIAMS NIH HHS/United States
- K24 AG031155/AG/NIA NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- DK31801/DK/NIDDK NIH HHS/United States
- U01-AR45647/AR/NIAMS NIH HHS/United States
- HL070847/HL/NHLBI NIH HHS/United States
- AG18037/AG/NIA NIH HHS/United States
- U01 AR45583/AR/NIAMS NIH HHS/United States
- 1 R01DE014386/DE/NIDCR NIH HHS/United States
- U01 AR045647/AR/NIAMS NIH HHS/United States
- U01 AR45580/AR/NIAMS NIH HHS/United States
- R01 AG026463-02/AG/NIA NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- U01 AR 45632-08A1/AR/NIAMS NIH HHS/United States
- AG026720/AG/NIA NIH HHS/United States
- U01 AR045580/AR/NIAMS NIH HHS/United States
- K23-RR020049/RR/NCRR NIH HHS/United States
- U01 AG18197/AG/NIA NIH HHS/United States
- U01 AG018197/AG/NIA NIH HHS/United States
- AG028507/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- R01-AG010897-22/AG/NIA NIH HHS/United States
- U01 AR045632/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical